Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review
Christo Kole, Εleni Stefanou, Nikolaos Karvelas, et al.
Cardiovascular Drugs and Therapy (2023)
Open Access | Times Cited: 22
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Lung (2023) Vol. 201, Iss. 2, pp. 135-147
Open Access | Times Cited: 10
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
Marco Mangiafico, Andrea Caff, Luca Costanzo
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 15
The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics
Friederike Eilts, Sarah Bauer, Keith Fraser, et al.
Carbohydrate Polymers (2022) Vol. 299, pp. 120167-120167
Open Access | Times Cited: 14
A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
Dimitrios Velissaris, Christos Michailides, Iosif Karalis, et al.
The Anatolian Journal of Cardiology (2023), pp. 232-239
Open Access | Times Cited: 5
Multisite spontaneous hematomas and bleeding in critically ill Chinese patients with COVID-19: two case reports and a literature review
Sha Sha, Sun Qi, Shi Qindong
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
COVID-19 Treatment—Current Status, Advances, and Gap
C. M. Ho, Lee C
Pathogens (2022) Vol. 11, Iss. 10, pp. 1201-1201
Open Access | Times Cited: 8
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis
Hong Duo, Yahui Li, Yujie Sun, et al.
Thrombosis Journal (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Polypharmacy and Drug Interactions in the COVID-19 Pandemic
Ricardo E Barcia, Guillermo Alberto Keller, Natalia Bello, et al.
Prague Medical Report (2023) Vol. 124, Iss. 4, pp. 392-412
Open Access | Times Cited: 2
Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials
Javier Ena, Victoria Valls
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 4, pp. 1189-1196
Open Access | Times Cited: 4
Therapeutic Applications of Fucoidans and their Potential to Act Against COVID-19
Dhananjay Yadav, Minseok Song
Current Pharmaceutical Design (2022) Vol. 28, Iss. 46, pp. 3671-3676
Closed Access | Times Cited: 4
Outcomes in Severe COVID-19 Patients Following Percutaneous Versus Open Surgical Tracheostomy: An Analysis of Clinical and Prognostic Indicators
Ali Akbari, Ramin Shekouhi, Vahid Khaloo, et al.
Cureus (2022)
Open Access | Times Cited: 3
The Comparison of Therapeutic With Prophylactic Anticoagulation on Mortality, Risk of Bleeding, and Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review
Nang I Kham, Rabia Shahid, Shaili S Naik, et al.
Cureus (2022)
Open Access | Times Cited: 2
COVID-19 related peripheral arterial thrombotic events in intensive care unit and non-intensive care unit patients: A retrospective case series
Petroula Nana, Konstantinos Dakis, Κωνσταντίνος Σπανός, et al.
Vascular (2022) Vol. 32, Iss. 2, pp. 366-373
Open Access | Times Cited: 2
Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes
Ya‐Hui Yu, In‐Sun Oh, Han Eol Jeong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 1
Low Molecular Weight Heparin Doses and Ventilator Airway Necessity in the COVID-19 Patients: Systematic Review and Meta-analysis
Yuyun Yueniwati, Mokhamad Fahmi Rizki Syaban, Athaya Febriantyo Purnomo, et al.
Open Access Macedonian Journal of Medical Sciences (2022) Vol. 10, Iss. F, pp. 241-245
Open Access
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis
Hong Duo, Yahui Li, Yujie Sun, et al.
Research Square (Research Square) (2022)
Closed Access
Special Issue “COVID-19 and Venous Thromboembolism”
Luca Costanzo
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3822-3822
Open Access
The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants
Mingyue Guo, Qi Han, Jiaxuan Xing, et al.
Emergency and Critical Care Medicine (2022) Vol. 2, Iss. 3, pp. 148-166
Open Access
Overview of the pharmaceutical market of anticoagulants for the treatment of coronavirus disease (COVID-19) during marital state in Ukraine
O. Zaliska, O. Semenov
Farmatsevtychnyi zhurnal (2022), Iss. 5, pp. 3-11
Open Access
Page 1

Scroll to top